ARCHIVES

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

The Meeting At the Beverly Hills Suite: Salick, Zeneca Par Way Acrimoniously

May 2, 1997

Full Funding Of Indirect Costs, Other Mandates By Congress Chew Up Most Of NCI’s Extra Money

December 2, 1983

Newest NIH Institute, NIBIB, Gets An Acting Director.

May 11, 2001

California approves $3 billion program for stem-cell research.

November 5, 2004

Swiss Report On Radiotherapy Mortality Questioned

January 7, 1977

Vasopermeation Technology Awarded Patent For CA Firm.

September 28, 2001